Residual DNA double strand breaks in perfused but not in unperfused areas determine different radiosensitivity of tumours

Radiotherapy and Oncology

Volumn 100, Issue 1, 2011, Pages 137-144

  Menegakis, Apostolos ^a,b   Eicheler, Wolfgang ^a,b   Yaromina, Ala ^a,b   Thames, Howard D ^c   Krause, Mechthild ^a,b   Baumann, Michael ^a,b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

H2AX; DNA repair; Hypoxia; Local tumour control; Perfusion; Radiotherapy

Indexed keywords

DOUBLE STRANDED DNA; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL HYPOXIA; CELL POPULATION; DNA DAMAGE; DNA REPAIR; DOUBLE STRANDED DNA BREAK; DOWN REGULATION; FEMALE; GENE EXPRESSION; MALE; MOUSE; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY;

AGED; AGED, 80 AND OVER; ANIMALS; BROMODEOXYURIDINE; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DNA BREAKS, DOUBLE-STRANDED; FEMALE; HISTONES; HUMANS; HYPOPHARYNGEAL NEOPLASMS; MALE; MICE; RADIATION TOLERANCE;

EID: 80051783228     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.07.001     Document Type: Article

References (57)

1. R.G. Bristow, H. Ozcelik, F. Jalali, N. Chan, and D. Vesprini Homologous recombination and prostate cancer: a model for novel DNA repair targets and therapies Radiother Oncol 83 2007 220 230 (Pubitemid 46915541)
2. N. Taneja, M. Davis, and J.S. Choy Histone H2AX phosphorylation as a predictor of radiosensitivity and target for radiotherapy J Biol Chem 279 2004 2273 2280 (Pubitemid 38084500)
3. H.P. Rodemann Molecular radiation biology: perspectives for radiation oncology Radiother Oncol 92 2009 293 298
4. P. Lassen The role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome Radiother Oncol 95 2010 371 380
5. M.C. de Jong, J. Pramana, and J.L. Knegjens HPV and high-risk gene expression profiles predict response to chemoradiotherapy in head and neck cancer, independent of clinical factors Radiother Oncol 95 2010 365 370
6. K.K. Ang, J. Harris, and R. Wheeler Human papillomavirus and survival of patients with oropharyngeal cancer N Engl J Med 363 2010 24 35
7. M. de Jong, J. Pramana, and J.E. van der Wal CD44 expression predicts local recurrence after radiotherapy in larynx cancer Clin Cancer Res 6 2010 5329 5338
8. M. Baumann, and M. Krause CD44: a cancer stem cell-related biomarker with predictive potential for radiotherapy Clin Cancer Res 16 2010 5091 5093
9. T. Helleday, J. Lo, D.C. van Gent, and B.P. Engelward DNA double-strand break repair: from mechanistic understanding to cancer treatment DNA Repair (Amst) 6 2007 923 935 (Pubitemid 46880473)
10. K. Koch, A. Wrona, E. Dikomey, and K. Borgmann Impact of homologous recombination on individual cellular radiosensitivity Radiother Oncol 90 2009 265 272
11. G. Iliakis Backup pathways of NHEJ in cells of higher eukaryotes: cell cycle dependence Radiother Oncol 92 2009 310 315
12. K. Rothkamm, I. Kruger, L.H. Thompson, and M. Lobrich Pathways of DNA double-strand break repair during the mammalian cell cycle Mol Cell Biol 23 2003 5706 5715 (Pubitemid 36951334)
13. E.P. Rogakou, D.R. Pilch, A.H. Orr, V.S. Ivanova, and W.M. Bonner DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139 J Biol Chem 273 1998 5858 5868 (Pubitemid 28124064)
14. J. Fillingham, M.C. Keogh, and N.J. Krogan GammaH2AX and its role in DNA double-strand break repair Biochem Cell Biol 84 2006 568 577 (Pubitemid 44703660)
15. E.P. Rogakou, C. Boon, C. Redon, and W.M. Bonner Megabase chromatin domains involved in DNA double-strand breaks in vivo J Cell Biol 146 1999 905 916
16. A. Kinner, W. Wu, C. Staudt, and G. Iliakis Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin Nucleic Acids Res 36 2008 5678 5694
17. D. Chowdhury, M.C. Keogh, H. Ishii, C.L. Peterson, S. Buratowski, and J. Lieberman Gamma-H2AX dephosphorylation by protein phosphatase 2A facilitates DNA double-strand break repair Mol Cell 20 2005 801 809 (Pubitemid 41740701)
18. D. Chowdhury, X. Xu, and X. Zhong A PP4-phosphatase complex dephosphorylates gamma-H2AX generated during DNA replication Mol Cell 31 2008 33 46 (Pubitemid 351905923)
19. M.C. Keogh, J.A. Kim, and M. Downey A phosphatase complex that dephosphorylates gammaH2AX regulates DNA damage checkpoint recovery Nature 439 2006 497 501 (Pubitemid 43152843)
20. W.M. Bonner, C.E. Redon, and J.S. Dickey GammaH2AX and cancer Nat Rev Cancer 8 2008 957 967
21. E. Soutoglou, and T. Misteli Activation of the cellular DNA damage response in the absence of DNA lesions Science 320 2008 1507 1510 (Pubitemid 351929432)
22. A. Takahashi, and T. Ohnishi Does gammaH2AX foci formation depend on the presence of DNA double strand breaks? Cancer Lett 229 2005 171 179 (Pubitemid 41429356)
23. K.J. McManus, and M.J. Hendzel ATM-dependent DNA damage-independent mitotic phosphorylation of H2AX in normally growing mammalian cells Mol Biol Cell 16 2005 5013 5025 (Pubitemid 41416478)
24. P. Porcedda, V. Turinetto, and L. Orlando Two-tier analysis of histone H2AX phosphorylation allows the identification of Ataxia Telangiectasia heterozygotes Radiother Oncol 92 2009 133 137
25. J.P. Banath, and P.L. Olive Expression of phosphorylated histone H2AX as a surrogate of cell killing by drugs that create DNA double-strand breaks Cancer Res 63 2003 4347 4350 (Pubitemid 36951002)
26. J.P. Banath, S.H. Macphail, and P.L. Olive Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines Cancer Res 64 2004 7144 7149 (Pubitemid 39331029)
27. S.H. MacPhail, J.P. Banath, T.Y. Yu, E.H. Chu, H. Lambur, and P.L. Olive Expression of phosphorylated histone H2AX in cultured cell lines following exposure to X-rays Int J Radiat Biol 79 2003 351 358 (Pubitemid 36920536)
28. S.H. MacPhail, J.P. Banath, Y. Yu, E. Chu, and P.L. Olive Cell cycle-dependent expression of phosphorylated histone H2AX: reduced expression in unirradiated but not X-irradiated G1-phase cells Radiat Res 159 2003 759 767 (Pubitemid 36676868)
29. R. Mirzayans, D. Severin, and D. Murray Relationship between DNA double-strand break rejoining and cell survival after exposure to ionizing radiation in human fibroblast strains with differing ATM/p53 status: implications for evaluation of clinical radiosensitivity Int J Radiat Oncol Biol Phys 66 2006 1498 1505
30. P.L. Olive, and J.P. Banath Phosphorylation of histone H2AX as a measure of radiosensitivity Int J Radiat Oncol Biol Phys 58 2004 331 335 (Pubitemid 38142456)
31. P.L. Olive, J.P. Banath, and L.T. Sinnott Phosphorylated histone H2AX in spheroids, tumors, and tissues of mice exposed to etoposide and 3-amino-1,2,4-benzotriazine-1,3-dioxide Cancer Res 64 2004 5363 5369 (Pubitemid 39006557)
32. C.A. Banuelos, J.P. Banath, J.Y. Kim, C. Aquino-Parsons, and P.L. Olive GammaH2AX expression in tumors exposed to cisplatin and fractionated irradiation Clin Cancer Res 15 2009 3344 3353
33. P.L. Olive, and J.P. Banath Kinetics of H2AX phosphorylation after exposure to cisplatin Cytometry B: Clin Cytom 76 2009 79 90
34. A. Menegakis, A. Yaromina, and W. Eicheler Prediction of clonogenic cell survival curves based on the number of residual DNA double strand breaks measured by gammaH2AX staining Int J Radiat Biol 85 2009 1032 1041
35. P.L. Olive, C.A. Banuelos, R.E. Durand, J.Y. Kim, and C. Aquino-Parsons Endogenous and radiation-induced expression of gammaH2AX in biopsies from patients treated for carcinoma of the uterine cervix Radiother Oncol 94 2010 82 89
36. A. Yaromina, D. Zips, and H.D. Thames Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies Radiother Oncol 81 2006 122 129 (Pubitemid 44780780)
37. A. Yaromina, H. Thames, and X. Zhou Radiobiological hypoxia, histological parameters of tumour microenvironment and local tumour control after fractionated irradiation Radiother Oncol 96 2010 116 122
38. W. Eicheler, D. Zips, A. Dorfler, R. Grenman, and M. Baumann Splicing mutations in TP53 in human squamous cell carcinoma lines influence immunohistochemical detection J Histochem Cytochem 50 2002 197 204 (Pubitemid 34106758)
39. U. Kasten-Pisula, A. Menegakis, and I. Brammer The extreme radiosensitivity of the squamous cell carcinoma SKX is due to a defect in double-strand break repair Radiother Oncol 90 2009 257 264
40. M. Baumann, W. Dubois, and H.D. Suit Response of human squamous cell carcinoma xenografts of different sizes to irradiation: relationship of clonogenic cells, cellular radiation sensitivity in vivo, and tumor rescuing units Radiat Res 123 1990 325 330 (Pubitemid 20327905)
41. M. Krause, C. Schutze, and C. Petersen Different classes of EGFR inhibitors may have different potential to improve local tumour control after fractionated irradiation: a study on C225 in FaDu hSCC Radiother Oncol 74 2005 109 115 (Pubitemid 40331867)
42. A. Yaromina, T. Holscher, and W. Eicheler Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma? Radiother Oncol 76 2005 206 212 (Pubitemid 41725449)
43. L.M. Cobb, J. Nolan, and S.A. Butler Distribution of pimonidazole and RSU 1069 in tumour and normal tissues Br J Cancer 62 1990 915 918
44. C. Rosenberger, C. Solovan, and A.D. Rosenberger Upregulation of hypoxia-inducible factors in normal and psoriatic skin J Invest Dermatol 127 2007 2445 2452 (Pubitemid 47619751)
45. H.L. Janssen, A.S. Ljungkvist, and P.F. Rijken Thymidine analogues to assess microperfusion in human tumors Int J Radiat Oncol Biol Phys 62 2005 1169 1175 (Pubitemid 40884432)
46. D. Zips, K. Le, and A. Yaromina Triple angiokinase inhibition, tumour hypoxia and radiation response of FaDu human squamous cell carcinomas Radiother Oncol 92 2009 405 410
47. K. Gulliksrud, I.K. Vestvik, K. Galappathi, B. Mathiesen, and E.K. Rofstad Detection of different hypoxic cell subpopulations in human melanoma xenografts by pimonidazole immunohistochemistry Radiat Res 170 2008 638 650
48. P.F. Rijken, H.J. Bernsen, J.P. Peters, R.J. Hodgkiss, J.A. Raleigh, and A.J. van der Kogel Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: a quantitative multi-parameter analysis Int J Radiat Oncol Biol Phys 48 2000 571 582
49. K. Rothkamm, and M. Lobrich Evidence for a lack of DNA double-strand break repair in human cells exposed to very low X-ray doses Proc Natl Acad Sci USA 100 2003 5057 5062 (Pubitemid 36542657)
50. R.G. Bristow, and R.P. Hill Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability Nat Rev Cancer 8 2008 180 192 (Pubitemid 351301853)
51. R.S. Bindra, S.L. Gibson, and A. Meng Hypoxia-induced down-regulation of BRCA1 expression by E2Fs Cancer Res 65 2005 11597 11604 (Pubitemid 41821719)
52. R.S. Bindra, P.J. Schaffer, and A. Meng Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells Mol Cell Biol 24 2004 8504 8518 (Pubitemid 39245072)
53. N. Chan, M. Koritzinsky, and H. Zhao Chronic hypoxia decreases synthesis of homologous recombination proteins to offset chemoresistance and radioresistance Cancer Res 68 2008 605 614 (Pubitemid 351380090)
54. A.X. Meng, F. Jalali, and A. Cuddihy Hypoxia down-regulates DNA double strand break repair gene expression in prostate cancer cells Radiother Oncol 76 2005 168 176 (Pubitemid 41725444)
55. J.H. Um, C.D. Kang, and J.H. Bae Association of DNA-dependent protein kinase with hypoxia inducible factor-1 and its implication in resistance to anticancer drugs in hypoxic tumor cells Exp Mol Med 36 2004 233 242 (Pubitemid 38981420)
56. J. Dahm-Daphi, T. Rieckmann, and R. Engenhart-Cabillic MicroRNA mediated ATM-depletion leads to a pronounced DNA repair defect and clinically manifest head and neck tumour radiosensitivity Strahlenther Onkol 187 2011 24
57. A.M. Walker, and H.D. Suit Assessment of local tumor control using censored tumor response data Int J Radiol Oncol Biol Phys 9 1983 383 386 (Pubitemid 13055184)